Без рубрики – CureLab Veterinary

October 12, 2024

CureLab Oncology's Elenagen: DNA Vaccine Shows Promise in Immuno-Oncology and Beyond

In August 2024, CureLab Oncology's CEO, Dr. Alexander Shneider, presented at the Immuno-Oncology Summit 2024. His presentation focused on the company's novel plasmid-based therapy, Elenagen, which initially aimed to be an anti-cancer DNA vaccine but serendipitously revealed broader therapeutic applications.

August 8, 2024

August 1, 2024
CureLab Veterinary Appoints Seasoned Industry Leader Alexis Nahama, DVM, as Executive Vice-President

Nahama to help the organization drive business development, investor relations, and licensing for innovative pet cancer therapies

June 14, 2024

June 14, 2024
Healing by Proxy: Newly Discovered Drug Elenagen May Treat Cancer and Inflammation Through Indirect Action

University of Camerino and CureLab Oncology announce strategic partnership to turn recent discovery into next-generation medicine

November 5, 2022

Novermber 5, 2022
Biotech Internship Opportunity! FDA/USDA liaison
CureLab Oncology and CureLab Veterinary are looking for interns to work with our FDA/USDA team on regulatory activities.

1 2
Next page